In results from a late-stage trial released in August, Vidaza was shown to have increased the survival of patients with a high-risk type of MDS from 15 months to 24 months.

FORBES: Magazine Article

These people see the federal budget deficit, the huge debt burden and the risk of a stagflation-type environment of low growth and high inflation, and cannot understand how investors could be piling into bonds.

FORBES: Five Bubbles Still In The Blowing Phase

Such patients are at high risk of death due to obesity-related illnesses, such as heart disease and type 2 diabetes.

CNN: Weight-loss surgery safe, but sleep apnea increases risk